This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Reproductive Disease Animal Model Development Service
Introduction
Are you navigating the complexities of reproductive research where suboptimal models hinder your progress? At BioVenic, we address your critical pain points in preclinical non-GLP studies. Our comprehensive development, characterization, and bio-sampling services leverage advanced modeling techniques to provide high-quality, reproducible animal models. Whether investigating underlying mechanisms or evaluating novel candidates, our integrated platform streamlines your workflow, ensuring robust data and scientific excellence from concept to validation.
BioVenic Reproductive Disease Animal Model Development Services
Reproductive Disease Animal Model Development
BioVenic specializes in the precise engineering of reproductive disease models across multiple species. Beyond standard offerings, we provide bespoke development services tailored to your specific research objectives. By integrating surgical interventions, hormonal manipulation, dietary induction, and advanced genetic engineering (KO/KI), we recreate specific pathological features. BioVenic's expertise ensures that each model is optimized for stability, reproducibility, and scientific relevance.
Reproductive Disease Animal Model Validation and Characterization
To ensure the integrity of your research, BioVenic performs comprehensive validation to confirm the successful establishment of the disease phenotype. Our scientists utilize a multi-parametric approach, including histopathological assessment (H&E, Masson's Trichrome), hormone profiling via ELISA (FSH, LH, E2, T), and imaging modalities (Ultrasound/MRI) to track lesion progression or organ morphology. This rigorous verification process guarantees that the model meets defined biological benchmarks before proceeding to downstream studies.
Comprehensive Sample Collection and Bioanalysis
BioVenic provides expert sampling of reproductive tissues and fluids, tailored to your downstream analytical needs. Our team is proficient in the collection of specialized specimens, including ovarian follicles, uterine tissue, vaginal lavage, prostate lobes, epididymal sperm, and serum/plasma. Samples can be processed for immediate analysis or preserved and shipped, maintaining the highest level of biological integrity.
Comprehensive Downstream Experimental Studies on Reproductive Disease Animal Models
Leverage our platform for extensive non-GLP preclinical investigations. BioVenic's downstream services include pharmacokinetic (PK) and pharmacodynamic (PD) profiling, reproductive toxicity assessments, sperm quality analysis, gene expression studies (qPCR, Western Blot), and immunohistochemistry (IHC). We provide the data-driven insights necessary to evaluate the biological impact of your candidates in a controlled, systemic environment.
Explore BioVenic's investigative modalities:
- Animal Behavioral Analysis
- Animal Histopathology Service
- Preclinical Animal Pharmacodynamics (PD) Study
- Preclinical Animal Pharmacokinetics (PK) Study
- Animal Cell Biology Service
- Animal lmaging Service
BioVenic's animal model development services also include:
- Genome-edited Animal Model Development
- Chemically-induced Animal Model Development
- Diet-induced Animal Model Development
- Surgically-induced Animal Model Development
Development Workflow for a Reproductive Disease Animal Model
Reproductive Disease Animal Models and Application Fields
Table. 1 Common Reproductive Disease Animal Models and Application Fields
| Disease Category | Animal Model Type | Induction Method(s) | Common Species | Research Applications |
|---|---|---|---|---|
| PCOS (Polycystic Ovary Syndrome) | Chemical / Dietary / Genetic | DHEA or Letrozole (LZ) combined with High-Fat Diet (HFD); Testosterone Propionate (TP); DHT; Gene knockout | Rats, Mice | Pathogenesis of PCOS, metabolic syndrome, infertility treatment. |
| Endometriosis | Transplantation / Surgical | Autologous/Allogeneic endometrial tissue transplantation; Sciatic nerve transplantation (for pain models) | Rats, Mice | Chronic pelvic pain, lesion growth inhibition, drug screening. |
| Prostatic Hyperplasia (BPH) | Hormonal / Surgical | Castration followed by Testosterone Propionate (TP) injection; Urogenital sinus induction | Rats, Mice | Hormone regulation, prostate volume reduction studies. |
| Prostatitis | Chemical / Pathogenic | Intraprostatic injection of Croton oil + Formaldehyde, Carrageenan, or E. coli | Rats | Anti-inflammatory drugs, non-bacterial/bacterial prostatitis research. |
| Thin Endometrium | Chemical | Ethanol (Alcohol) intrauterine infusion | Rats, Rabbits | Regenerative medicine, stem cell therapy, fertility restoration. |
| Intrauterine Adhesions (IUA) | Mechanical / Chemical | Uterine curettage combined with ethanol infusion or mechanical injury | Rats, Rabbits | Pathogenesis of Asherman's syndrome, anti-fibrotic treatments. |
| Premature Ovarian Failure (POF) | Chemical / Physical / Genetic | Cyclophosphamide, Busulfan, D-galactose, or Irradiation; Gene knockout | Mice, Rats | Ovarian function protection, hormone replacement therapy. |
| Menopause / Perimenopause | Surgical | Bilateral Ovariectomy (OVX) | Rats | Postmenopausal obesity, bone density loss, vaginal atrophy. |
| Vaginitis | Pathogenic / Hormonal | Estradiol combined with mixed bacterial flora (Bacterial) or OVX (Atrophic) | Rats, Mice | Antimicrobial efficacy, hormonal therapy for vaginal health. |
| Male Infertility | Physical / Genetic / Surgical | Heat stress, radiation, Varicocele (Vein ligation), or Gene knockout | Mice, Rats | Spermatogenesis defects, azoospermia, varicocelerepair. |
| Erectile Dysfunction (ED) | Surgical | Cavernous nerve injury (Neurogenic ED) | Rats | Nerve regeneration, erectile function recovery. |
| Mastitis | Pathogenic | Lipopolysaccharide (LPS) mammary gland infusion | Rats, Mice | Inflammatory response, mammary tissue protection. |
| Hypospadias | Chemical | DBP (Dibutyl Phthalate) or Finasteride induction during pregnancy | Rats, Mice | Developmental toxicology, congenital malformations. |
| Reproductive Cancers | Xenograft | Human/Murine cell line transplantation (Ovarian, Endometrial, Cervical, Prostate cancer) | Nude Mice | Oncology, tumor growth inhibition, chemotherapy. |
Advantages of BioVenic Reproductive Disease Animal Model Development Service
Diverse Modeling Methodologies
BioVenic combines genetic, chemical, dietary, and surgical techniques to build complex reproductive phenotypes. Whether it is a DHEA-induced PCOS rat or a surgical endometriosis model, we select the method that best aligns with your scientific hypothesis.
Scientific Customization
No two projects are identical. We tailor the animal strain, induction timeline, and dosage regimens based on existing literature and your unique requirements to ensure the most reliable experimental outcomes.
Robust Analytical Platform
Our facility is equipped for high-precision detection. BioVenic offers a wide array of animal reproductive-specific assays, including AMH levels, progesterone assays, testosterone quantification, and other measurements.
Integrated One-Stop Solution
From the initial model design to final tissue analysis, BioVenic manages the entire lifecycle of your project. This vertical integration reduces lead times, minimizes inter-operator variability, and provides a cohesive data package.
Case Study: PCOS Endocrine & Ovarian Function Evaluation
BioVenic provides a high-fidelity polycystic ovary syndrome (PCOS) model designed to simulate the complex endocrine and morphological hallmarks of the human condition. Our service ensures rigorous validation of the disease state through estrous cycle monitoring (identifying persistent diestrus) and detailed ovarian histopathology to quantify cystic follicle formation and follicular atresia. To assess systemic metabolic impact, we offer precise serum profiling of testosterone and insulin levels. This mature modeling suite is specifically optimized for evaluating the therapeutic potential of metabolic regulators and antioxidants, providing quantitative data on the restoration of ovarian function and ovulation. By integrating molecular analysis of the PPAR-gamma signaling pathway and enzymatic assays for oxidative stress (SOD and GPx), we deliver the high-resolution mechanistic insights necessary to validate your candidates for PCOS management.
Fig. 1 DHEA induced the PCOS model in rats1
FAQs
Q: What species do you support for non-GLP preclinical studies?
A: Our primary expertise covers rodents (mice, rats), but we also offer services for larger species such as rabbits for specific research needs.
Q: How do you ensure the stability of the disease phenotype?
A: Every model undergoes a validation phase where we monitor biomarkers and physical indicators. BioVenic only proceeds to the experimental phase once the model consistently meets pre-set inclusion criteria.
Q: Can you handle the administration of our proprietary test articles?
A: Yes, we are experienced in various administration routes and can implement complex dosing schedules as part of our experimental service.
Contact Us
Elevate your reproductive research with high-precision animal models and expert non-GLP experimental services. At BioVenic, we provide the technical mastery and analytical depth required to transform your scientific questions into clear, actionable data. From custom model development to sophisticated downstream bio-analysis, we are your dedicated partner in preclinical discovery. Contact our scientific team today for a customized quote and consultation.
Reference
- Zhang, Wei et al. "The therapeutic effects of curcumin on polycystic ovary syndrome by upregulating PPAR-γ expression and reducing oxidative stress in a rat model." Frontiers in endocrinology vol. 15 1494852. 20 Nov. 2024. https://doi.org/10.3389/fendo.2024.1494852. Distributed under Open Access license CC BY 4.0. Without Modification.